Construction and Testing of Two Distinct Humanized CD19-Specific Chimeric Antigen Receptors (CARs) for the Treatment of B-Cell Malignancies

被引：0
|
作者：
Gopalakrishnan, Ramakrishnan [1 ]
Matta, Hittu [1 ]
Choi, Sunju [2 ]
Han, Xu [2 ]
Prakash, Rekha [2 ]
Narasappa, Nell [2 ]
Gong, Songjie [2 ]
Chitnis, Saurabh [2 ]
Kahn, Michael [2 ]
Sernas, Jennifer [2 ]
Khan, Prottasha [2 ]
Chaudhary, Preet [2 ]
机构：
[1] Univ So Calif, Ctr Study Blood Dis, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Los Angeles, CA 90033 USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.4025.4025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4025
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Chimeric antigen receptors: a costimulatory boost promotes immunological memory to B-cell malignancies
    Peggs, Karl S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (11) : 1667 - 1670
  • [22] Modification of hematopoietic stem cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy
    De Oliveira, Satiro N.
    Ryan, Christine
    Wherley, Jennifer
    Tu, Andy
    Elashoff, David
    Cooper, Laurence J. N.
    Hollis, Roger P.
    Kohn, Donald B.
    CANCER RESEARCH, 2014, 74 (20)
  • [23] Subcutaneous immunoglobulin replacement following CD19-specific chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia in pediatric patients
    Arnold, Danielle E.
    Maude, Shannon L.
    Callahan, Colleen A.
    DiNofia, Amanda M.
    Grupp, Stephan A.
    Heimall, Jennifer R.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (03)
  • [24] T Cells Expressing Anti B-Cell Maturation Antigen Chimeric Antigen Receptors for Plasma Cell Malignancies
    Li, Chunrui
    Wang, Qiuxiang
    Zhu, Hui
    Mao, Xia
    Wang, Ying
    Zhang, Yicheng
    Zhou, Jianfeng
    BLOOD, 2018, 132
  • [25] PiggyBac, an Efficient Method for Genetic Modification of T Cells with Second Generation CD19-Specific Chimeric Antigen Receptor (CAR) for Treatment of B-Lineage Malignancies
    Manuri, Pallavi R.
    Maiti, Sourindra N.
    Singh, Harjeet
    Mi, Tiejuan
    Olivares, Simon
    Dawson, Margaret J.
    Huls, Helen
    Lee, Dean A.
    Rao, Pulivarthi H.
    Kaminski, Joseph M.
    Kebriaei, Partow
    Wilson, Matthew H.
    Cooper, Laurence J. N.
    MOLECULAR THERAPY, 2009, 17 : S212 - S213
  • [26] Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies
    Cooper, LJN
    Al-Kadhimi, Z
    DiGiusto, D
    Kalos , M
    Colcher, D
    Raubitschek, A
    Forman, SJ
    Jensen, MC
    BLOOD CELLS MOLECULES AND DISEASES, 2004, 33 (01) : 83 - 89
  • [27] CD19-Specific Chimeric Antigen Receptor-Modified T Cells with Safety Switch Produced Under "Point-of-Care" Using the Sleeping Beauty System for the Very Rapid Manufacture and Treatment of B-Cell Malignancies
    Chan, Tim
    Gallagher, John
    Cheng, Nai-Lin
    Carvajal-Borda, Fernando
    Plummer, Jacques
    Govekung, Adeline
    Barrett, John A.
    Khare, Pranay D.
    Cooperand, Laurence J. N.
    Shah, Rutul R.
    BLOOD, 2017, 130
  • [28] Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies
    Garcia-Prieto, Carlos A.
    Villanueva, Lorea
    Bueno-Costa, Alberto
    Davalos, Veronica
    Azucena Gonzalez-Navarro, Europa
    Juan, Manel
    Urbano-Ispizua, Alvaro
    Delgado, Julio
    Ortiz-Maldonado, Valentin
    Del Bufalo, Francesca
    Locatelli, Franco
    Quintarelli, Concetta
    Sinibaldi, Matilde
    Soler, Marta
    Castro de Moura, Manuel
    Ferrer, Gerardo
    Urdinguio, Rocio G.
    Fernandez, Agustin F.
    Fraga, Mario F.
    Bar, Diana
    Meir, Amilia
    Itzhaki, Orit
    Besser, Michal J.
    Avigdor, Abraham
    Jacoby, Elad
    Esteller, Manel
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (03): : 436 - 445
  • [29] CD19-Targeted Chimeric Antigen Receptor-Modified T-Cell Immunotherapy for B-Cell Malignancies
    Turtle, C. J.
    Riddell, S. R.
    Maloney, D. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (03) : 252 - 258
  • [30] Modification of Hematopoietic Stem/Progenitor Cells with CD19-Specific Chimeric Antigen Receptors as a Novel Approach for Cancer Immunotherapy
    De Oliveira, Satiro Nakamura
    Ryan, Christine
    Giannoni, Francesca
    Hardee, Cinnamon L.
    Tremcinska, Irena
    Katebian, Behrod
    Wherley, Jennifer
    Sahaghian, Arineh
    Tu, Andy
    Grogan, Tristan
    Elashoff, David
    Cooper, Laurence J. N.
    Hollis, Roger P.
    Kohn, Donald B.
    HUMAN GENE THERAPY, 2013, 24 (10) : 824 - 839
12345